Form 4: Inspire Medical Systems Executive Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Carlton Weatherby, Chief Strategy and Growth Officer at Inspire Medical Systems, reports the acquisition and disposal of company stock.

Summary

  • Carlton Weatherby, Chief Strategy and Growth Officer of Inspire Medical Systems, filed a Form 4 detailing changes in beneficial ownership.
  • On February 9, 2025, 313 shares of common stock were disposed of at a price of $182.15.
  • On February 13, 2025, 5,076 shares of common stock were acquired at $0.00.
  • Following these transactions, Weatherby directly owns 7,457 shares of Inspire Medical Systems common stock.
  • The acquisition on February 13, 2025, represents an award of restricted stock units that vest in three equal annual installments starting February 13, 2026.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects routine stock transactions by an executive. The acquisition of restricted stock units is generally a positive sign, but it's a standard practice.

Positives

  • The acquisition of 5,076 shares indicates continued alignment of the executive's interests with the company's performance.
  • The vesting schedule of the restricted stock units incentivizes long-term commitment from the executive.

Future Outlook

The vesting schedule of the restricted stock units suggests an expectation of continued employment and company performance over the next three years.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates standard compensation practices using restricted stock units.

Comparison to Industry Standards

  • Restricted stock units are a common form of executive compensation in the medical device industry, aligning executive incentives with shareholder value.
  • Companies like Medtronic and Stryker also utilize similar equity-based compensation plans for their executives.

Stakeholder Impact

  • The transactions provide transparency to shareholders regarding executive compensation and stock ownership.
  • The vesting schedule of the restricted stock units aligns executive interests with long-term shareholder value.

Key Dates

DateDescription
02/09/2025Disposal of 313 shares of common stock at $182.15 per share.
02/13/2025Acquisition of 5,076 restricted stock units at $0.00 per share.
02/13/2026First vesting date for the restricted stock units.
02/18/2025Date of Form 4 filing.

Keywords

Form 4, Insider Trading, Stock Transactions, Beneficial Ownership, Inspire Medical Systems, INSP, Carlton Weatherby, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.